CPRT.NASDAQCopart INC

Form 4: Copart Director Granted 17,813 Stock Options

Sentiment:

Insider Transaction Report


Copart Inc. Director Cherylyn Harley LeBon was granted 17,813 stock options with an exercise price of $38.72, vesting over 12 months.

Summary

  • Director Cherylyn Harley LeBon of Copart Inc. was granted 17,813 stock options.
  • The options have an exercise price of $38.72 per share.
  • These options were granted on December 5, 2025, under the company's 2007 Equity Incentive Plan.
  • The options will vest on a monthly basis over the 12 months succeeding the grant date, completing by December 5, 2026.
  • The expiration date for these options is December 5, 2032.
  • Following this transaction, Ms. LeBon directly beneficially owns 17,813 derivative securities.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The grant of stock options is a routine compensation event for a director, aligning their interests with the company's long-term performance. It is not a major operational or financial announcement but reflects standard corporate governance.

Positives

  • The grant of stock options aligns the director's interests with long-term shareholder value.
  • The options were granted under an existing 2007 Equity Incentive Plan, indicating a structured and established compensation approach.

Future Outlook

This filing reports a historical transaction and does not provide forward-looking statements regarding the company's financial performance or strategic direction. It indicates the future potential for the director to exercise the granted options.

Industry Context

The grant of stock options to a director is a routine compensation practice in publicly traded companies, aiming to incentivize long-term performance and align management interests with shareholder value. This disclosure reflects standard corporate governance and compensation mechanisms rather than specific industry trends.

Comparison to Industry Standards

  • Granting stock options to directors is a common practice across publicly traded companies to incentivize long-term performance and align interests with shareholders.
  • The 12-month monthly vesting schedule is a standard approach to retain talent and ensure continued engagement.
  • Setting the exercise price at the market price on the grant date (implied for typical stock options) is also a standard industry practice.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Adherence to PolicyThe stock options were granted under the company's established 2007 Equity Incentive Plan, indicating adherence to existing corporate governance frameworks for executive compensation.12/05/2025Reinforces the company's structured approach to director compensation and alignment with shareholder interests.

Related Party Transactions

  • The grant of 17,813 stock options to Cherylyn Harley LeBon, a director of Copart Inc., constitutes a related party transaction.

Stakeholder Impact

  • Shareholders: Potential for future dilution if options are exercised, but also benefits from increased alignment of director's interests with long-term company performance.
  • Employees: No direct impact on general employees is mentioned in this filing.

Next Steps

  • The director may exercise these options at any time after they vest and before their expiration date.

Key Dates

DateDescription
12/05/2025Date of earliest transaction (grant of stock options)
12/09/2025Date the Form 4 was signed by the attorney-in-fact
12/05/2026Estimated date by which all granted stock options will be fully vested
12/05/2032Expiration date of the granted stock options

Keywords

Copart, CPRT, Stock Options, Insider Transaction, Form 4, Equity Incentive Plan, Director Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.